MiR-21, a prototypical oncogenic miRNA, reigns supreme in glioblastoma, promoting tumor growth and therapy resistance by targeting tumor suppressors such as PTEN and PDCD4 [127]. This evidence concerns the gene PDCD4 and neoplasm.